Home   >  
GPCR/G Protein
  >  
Endothelin Receptor

Classified by application

All Products

Signaling Pathways

Research Areas

Nature products

Antibodies

Peptides

Catalysts

Impurities

Intermediate

Raw Materials

Endothelin Receptor

Chemical Structure Cat. No. Product Name CAS No.
Aprocitentan Chemical Structure
BCP28125 Aprocitentan 1103522-45-7
Aprocitentan is the major and pharmacologically active metabolite of macitentan, which is dual ETA/ETB antagonist designed for tissue targeting.
BQ-123 Chemical Structure
BCP29354 BQ-123 136553-81-6
BQ-123 is a elective ETA endothelin receptor antagonist (Ki values are 1.4 and 1500 nM at ETA and ETB receptors respectively).
Ro 46-2005 Chemical Structure
BCP17756 Ro 46-2005 150725-87-4
Ro 46-2005 is a novel synthetic non-peptide endothelin receptor antagonist, inhibits the specific binding of 125I-ET-1 to human vascular smooth muscle cells (ETA receptor) with IC50 of 220 nM.
IRL-1620 Chemical Structure
BCP09112 IRL-1620 142569-99-1
IRL-1620, also known as SPI-1620, is an endothelin B receptor agonist.
Sitaxsentan sodium Chemical Structure
BCP08362 Sitaxsentan sodium 210421-74-2
Sitaxsentan sodium (TBC11251 sodium salt) is an orally active, highly selective antagonist of endothelin A receptors.
Ambrisentan Chemical Structure
BCP22426 Ambrisentan 177036-94-1
Ambrisentan is a selective ET type A receptor (ETAR) antagonist.
Endothelin-1 Acetate Chemical Structure
BCP27613 Endothelin-1 Acetate 117399-94-7
Endothelin 1 (swine, human) is a synthetic peptide with the sequence of human and swine Endothelin 1, which is a potent endogenous vasoconstrictor. Endothelin 1 acts through two types of receptors ETA and ETB.
Bosentan Chemical Structure
BCP05202 Bosentan 147536-97-8
Bosentan is a competitive and dual antagonist of endothelin-1 at the endothelin-A (ET-A) and endothelin-B (ET-B) receptors.
Atrasentan Chemical Structure
BCP17322 Atrasentan 173937-91-2
Atrasentan is an endothelin receptor antagonist with IC50 of 0.0551 nM for ETA.
Atrasentan hydrochloride Chemical Structure
BCP19490 Atrasentan hydrochloride 195733-43-8
Atrasentan Hcl(A-147627) is an endothelin antagonist receptor (IC50=0.0551 nM, ETA) being developed for the treatment of prostate cancer.
12下一页共 14 条记录 1 / 2 页 
0086-13720134139